Empowering Companies Through Our Unique, Results-Driven Approach to
Business Development, Legal Services, and Negotiations.

OssDsign AB’s Testimonial of B2World’s U.S. Market Entry Services

//OssDsign AB’s Testimonial of B2World’s U.S. Market Entry Services

OssDsign AB’s Testimonial of B2World’s U.S. Market Entry Services

OssDsign AB is a Swedish med-tech company emerging from academic research by Clinical Researchers at Karolinska Hospital and Biomaterial Researchers at Uppsala University. OssDsign has developed a unique technology for 3-D printed, patient specific, bioactive implants addressing clinical complications related to traditional implant technologies. Key to OssDsign’s business objectives is a successful rollout in the U.S.—currently slated for 2017. B2World has been instrumental in the strategic work defining the market entry strategy, identifying/managing potential risks, and developing partner contracts. B2World’s in-depth understanding of the U.S. market combined with a motivation to understand our business and the specific challenges of a start-up with high ambitions added substantial value in our planning for the U.S. market introduction and OssDsign’s future success.

Anders Lundqvist, CEO OssDsign AB

 

 

 

 

 

2017-02-03T02:35:54+00:00